Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Propaganda vs. Promise: Why Israel Stands—and Will Always Stand

Israel, the Media War, and the U.S. Alliance: What’s Really…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Practice or Prophecy? The Day a Red Heifer Became a Turning Point in History

Red Heifer Ceremony in Israel: What Happened July 1—and Why…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Inside the Hunt for the Red Heifer: The Ceremony That Shocked Israel

A Texas Rancher, Five Red Heifers, and a Ceremony Stirring Prophetic…
Read more